Učitavanje...
COVID‐19 and immunosuppressive therapy in dermatology
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become a...
Spremljeno u:
| Izdano u: | Dermatol Ther |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435553/ https://ncbi.nlm.nih.gov/pubmed/32770592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.14140 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|